drug · small molecule
patient view →lenvatinib mesylate
Marketedupdated 2mo agoby Eisai Co Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 2 investigational indications.
indications
investigational
Colorectal CancerMelanoma
targets
Vascular endothelial growth factor receptor
all catalysts(2)
drug expiry · 1
patent expiry · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that